Pacific Edge seeks Medicare reinstatement for Cxbladder
Cancer diagnostics company Pacific Edge (ASX:PEB) has released its investor update for the three months ended December 2025.
Cancer diagnostics company Pacific Edge (ASX:PEB) has released its investor update for the three months ended December 2025.
Mining of the first ore panels at Lefroy Exploration's (ASX:LEX) Lucky Strike Gold Deposit, near Kalgoorlie in Western Australia, is now underway.
Nanoveu (ASX:NVU), an Australian technology innovator in semiconductors and advanced materials, has raised $7.5 million through a share placement to fund the commercialisation of its EMASS ECS-DoT system-on-chip platform.
GoldArc Resources (ASX:GA8) has consolidated full ownership of the Mt Stirling deposit (M37/1306), acquiring the remaining 10% interest and converting it into a 2% gross smelter royalty.
Most Australian workers are experimenting with artificial intelligence in their personal lives, but experts say clearer guidelines and greater control are needed for widespread adoption at work.
Summerset Group (ASX:SNZ) recorded 448 sales for the quarter ended Dec. 31, 2025, consisting of 207 new sales and 241 resales, capping a full-year total of 1,560 settlements—up 26 percent from FY24.
29Metals (ASX:29M) has announced a fully underwritten 1-for-3.66 accelerated pro-rata non-renounceable entitlement offer to raise $150 million before costs.
Superannuation giant Aware Super is set to invest US$300 million to acquire a minority stake in the Asia-Pacific arm of US-based Vantage Data Center.
Northern Star Resources (ASX:NST) has updated its FY26 all-in sustaining cost guidance after revising its production outlook earlier this month.
ARB (ASX:ARB) has reported that unaudited management accounts for the six months ended Dec. 31, 2025 show total sales revenue of $358 million.
Rent.com.au (ASX:RNT) has reported a record-breaking quarter, surpassing $1 million in revenue for the first time.
Telix Pharmaceuticals (ASX:TLX) announced that China's National Medical Products Administration has accepted its New Drug Application for TLX591-Px .